Andrei I. Chapoval

5.3k total citations · 2 hit papers
60 papers, 4.4k citations indexed

About

Andrei I. Chapoval is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrei I. Chapoval has authored 60 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 23 papers in Oncology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrei I. Chapoval's work include Immunotherapy and Immune Responses (32 papers), Immune Cell Function and Interaction (25 papers) and T-cell and B-cell Immunology (23 papers). Andrei I. Chapoval is often cited by papers focused on Immunotherapy and Immune Responses (32 papers), Immune Cell Function and Interaction (25 papers) and T-cell and B-cell Immunology (23 papers). Andrei I. Chapoval collaborates with scholars based in United States, Russia and China. Andrei I. Chapoval's co-authors include Lieping Chen, Koji Tamada, Gefeng Zhu, Dallas B. Flies, Jian Ni, Ryan A. Wilcox, Gabriel Sica, Scott E. Strome, Haidong Dong and Julie S. Lau and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Andrei I. Chapoval

58 papers receiving 4.3k citations

Hit Papers

B7-H3: A costimulatory molecule for T cell activation and... 2001 2026 2009 2017 2001 2003 250 500 750

Peers

Andrei I. Chapoval
Tahiro Shin United States
Jeong Kim United States
Maria-Luisa Alegre United States
Cory L. Ahonen United States
Ainhoa Arina United States
Andrei I. Chapoval
Citations per year, relative to Andrei I. Chapoval Andrei I. Chapoval (= 1×) peers Segundo González

Countries citing papers authored by Andrei I. Chapoval

Since Specialization
Citations

This map shows the geographic impact of Andrei I. Chapoval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei I. Chapoval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei I. Chapoval more than expected).

Fields of papers citing papers by Andrei I. Chapoval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrei I. Chapoval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei I. Chapoval. The network helps show where Andrei I. Chapoval may publish in the future.

Co-authorship network of co-authors of Andrei I. Chapoval

This figure shows the co-authorship network connecting the top 25 collaborators of Andrei I. Chapoval. A scholar is included among the top collaborators of Andrei I. Chapoval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrei I. Chapoval. Andrei I. Chapoval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jain, Anshika, Gaspar E. Cánepa, Mei-Ling Liou, et al.. (2024). Multiple treatment interruptions and protecting HIV-specific CD4 T cells enable durable CD8 T cell response and viral control. Frontiers in Medicine. 11. 1342476–1342476. 1 indexed citations
2.
Щербаков, Д. Н., et al.. (2023). The effect of thioredoxin and prochymosin coexpression on the refolding of recombinant alpaca chymosin. Vavilov Journal of Genetics and Breeding. 27(4). 421–427.
3.
Borisevich, Sophia S., Alexander A. Bondar, Yuri B. Porozov, et al.. (2022). Can Modern Molecular Modeling Methods Help Find the Area of Potential Vulnerability of Flaviviruses?. International Journal of Molecular Sciences. 23(14). 7721–7721. 5 indexed citations
4.
Chapoval, Andrei I., et al.. (2021). Recent advances in potentiometric biosensing. Current Opinion in Electrochemistry. 28. 100735–100735. 49 indexed citations
5.
Chapoval, Andrei I., Glennda Smithson, Mehdi Mesri, et al.. (2013). BTNL8, a butyrophilin-like molecule that costimulates the primary immune response. Molecular Immunology. 56(4). 819–828. 27 indexed citations
6.
Zhang, Yue, Lukas W. Pfannenstiel, Carolina L. Montes, et al.. (2011). Interleukin-7 Inhibits Tumor-Induced CD27−CD28− Suppressor T Cells: Implications for Cancer Immunotherapy. Clinical Cancer Research. 17(15). 4975–4986. 28 indexed citations
7.
Chapoval, Andrei I., et al.. (2010). Repertoire Development and the Control of Cytotoxic/Effector Function in Human γδ T Cells. Journal of Immunology Research. 2010(1). 732893–732893. 28 indexed citations
8.
Zhang, Xiaoyu, Caroline Voskens, Michelle A. Sallin, et al.. (2009). CD137 Promotes Proliferation and Survival of Human B Cells. The Journal of Immunology. 184(2). 787–795. 54 indexed citations
9.
Taylor, Rodney J., Caroline Voskens, Jeffrey S. Wolf, et al.. (2008). FcγRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck. Cancer Immunology Immunotherapy. 58(7). 997–1006. 81 indexed citations
10.
Luo, Liqun, Andrei I. Chapoval, Dallas B. Flies, et al.. (2004). B7-H3 Enhances Tumor Immunity In Vivo by Costimulating Rapid Clonal Expansion of Antigen-Specific CD8+ Cytolytic T Cells. The Journal of Immunology. 173(9). 5445–5450. 152 indexed citations
11.
Wilcox, Ryan A., Dallas B. Flies, Gefeng Zhu, et al.. (2002). Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. Journal of Clinical Investigation. 109(5). 651–659. 185 indexed citations
12.
Wilcox, Ryan A., Dallas B. Flies, Gefeng Zhu, et al.. (2002). Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. Journal of Clinical Investigation. 109(5). 651–659. 9 indexed citations
13.
Chapoval, Svetlana P., Koji Iijima, Eric Marietta, et al.. (2002). Allergic Inflammatory Response to Short Ragweed Allergenic Extract in HLA-DQ Transgenic Mice Lacking CD4 Gene. The Journal of Immunology. 168(2). 890–899. 14 indexed citations
14.
Wilcox, Ryan A., Andrei I. Chapoval, Kevin Gorski, et al.. (2002). Cutting Edge: Expression of Functional CD137 Receptor by Dendritic Cells. The Journal of Immunology. 168(9). 4262–4267. 189 indexed citations
15.
Wilcox, Ryan A., Dallas B. Flies, Gefeng Zhu, et al.. (2002). Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. Journal of Clinical Investigation. 109(5). 651–659. 219 indexed citations
16.
Tamada, Koji, Koji Shimozaki, Andrei I. Chapoval, et al.. (2000). Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nature Medicine. 6(3). 283–289. 269 indexed citations
17.
Rice, David C., et al.. (1999). Induction of antitumor immunity after cure of pulmonary metastases, using staphylococcal enterotoxin B and bispecific antibody. Cancer Immunology Immunotherapy. 48(5). 230–238. 2 indexed citations
18.
Kremlev, Sergey G., Andrei I. Chapoval, & Robert L. Evans. (1998). CSF-1 (M-CSF) Enhances the Inflammatory Response of Fibronectin-Primed Macrophages: Pathways Involved in Activation of the Cytokine Network. PubMed. 16(5-6). 228–243. 9 indexed citations
19.
Kamdar, Sonya, et al.. (1996). Differential Sensitivity of Mouse Mononuclear Phagocytes to CSF-1 and LPS: The Potentialin VivoRelevance of Enhanced IL-6 Gene Expression. Cellular Immunology. 174(2). 165–172. 17 indexed citations
20.
Chapoval, Andrei I., et al.. (1995). Bifunctional Antibody Retargeting In Vivo-Activated T Lymphocytes: Simplifying Clinical Application. Journal of Hematotherapy. 4(6). 571–577. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026